S 1521
117th Congress
Senate
Health
Banking and financial institutions regulation
Cancer
Child health
Civil actions and liability
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government trust funds
Health programs administration and funding
Medical research
National Institutes of Health (NIH)
Research administration and funding
Securities
Securities and Exchange Commission (SEC)
Gabriella Miller Kids First Research Act 2.0
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 29, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2365)
Apr 29, 2021
Introduced in Senate
Plain-English summary
Gabriella Miller Kids First Research Act 2.0
This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH).
Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund.
This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2365)
Committees of jurisdiction
1